Rise and shine, everyone. Another day has arrived. We have gotten off to a reasonable start by hustling one of the short people to the schoolhouse on time. Of course, there is still much to do. So join us as we peruse the news of the world and celebrate the passing of another year with a cup of stimulation. Hope your day goes well and do stay in touch...
Lundbeck Buys Rights To Merck's Bipolar Disorder Drug (Bloomberg News)
Halozyme Cuts Workforce By 25 Percent (InPharma-Technologist)
Sara Bloom Fights Health Care Fraud (The Washington Post)
Four Big Drugmakers Bid For Paras Pharma (The Business Standard)
Pfizer Reports Promising Data On NSCLC Drug (PharmaTimes)
Turkey's Biofarma May Be For Sale (Reuters)